We are live on ! Find out more
ACHL

Achilles Therapeutics
ACHL

Delisted

ACHL was delisted on the 20th of March, 2025.

Back to rankings

29 hedge funds and large institutions have $278M invested in Achilles Therapeutics in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
29
Holders Change
+29
Holders Change %
–
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$42.9M
2
AG
Artal Group
Luxembourg
+$37.3M
3
RG
Redmile Group
California
+$34.6M
4
O
OrbiMed
New York
+$26.2M
5
BC
Boxer Capital
California
+$25.4M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$42.9M +$42.9M +2,591,366 New
AG
2
Artal Group
Luxembourg
$37.3M +$37.3M +2,255,375 New
RG
3
Redmile Group
California
$34.6M +$34.6M +2,088,089 New
O
4
OrbiMed
New York
$26.2M +$26.2M +1,584,845 New
BC
5
Boxer Capital
California
$25.4M +$25.4M +1,536,208 New
RCM
6
RA Capital Management
Massachusetts
$23M +$23M +1,388,888 New
FCM
7
Farallon Capital Management
California
$16.6M +$16.6M +1,000,000 New
DM
8
Deerfield Management
New York
$13.2M +$13.2M +800,000 New
PA
9
Perceptive Advisors
New York
$12.5M +$12.5M +755,375 New
JP Morgan Chase
10
JP Morgan Chase
New York
$10.4M +$10.4M +625,750 New
Bank of America
11
Bank of America
North Carolina
$9.54M +$9.53M +576,085 New
PCM
12
Peregrine Capital Management
Minnesota
$5.33M +$5.33M +322,261 New
SFM
13
Sphera Funds Management
Israel
$4.96M +$4.96M +300,000 New
WP
14
Woodline Partners
California
$3.95M +$3.95M +238,822 New
Millennium Management
15
Millennium Management
New York
$3.36M +$3.36M +202,785 New
MIM
16
Monashee Investment Management
Massachusetts
$2.07M +$2.07M +125,000 New
PVI
17
Pura Vida Investments
New York
$1.71M +$1.71M +103,026 New
Macquarie Group
18
Macquarie Group
Australia
$914K +$914K +55,247 New
CCM
19
CAAS Capital Management
New York
$828K +$828K +50,000 New
Citadel Advisors
20
Citadel Advisors
Florida
$650K +$650K +39,253 New
Alyeska Investment Group
21
Alyeska Investment Group
Illinois
$533K +$533K +32,230 New
Squarepoint
22
Squarepoint
New York
$463K +$463K +28,000 New
AAA
23
Affinity Asset Advisors
New York
$414K +$414K +25,000 New
Norges Bank
24
Norges Bank
Norway
$414K +$414K +25,000 New
BlackRock
25
BlackRock
New York
$413K +$414K +25,000 New
1
2

ACHL Hedge Fund Activity: Q1 2021 in Review

29 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Achilles Therapeutics (ACHL) for Q1 2021, worth a combined $278M.

Buyers outnumbered sellers: 29 funds opened new ACHL positions and 0 closed out — a net gain of 29 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $42.9M.

  • 29 institutional investors held Achilles Therapeutics (ACHL) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $278M of Achilles Therapeutics stock for Q1 2021.
  • 29 funds opened new Achilles Therapeutics positions in Q1 2021 and 0 closed out, a net change of +29 holders.
  • The largest Achilles Therapeutics buyer in Q1 2021 was Baker Bros. Advisors, an estimated $42.9M added.

Based on aggregated 13F filings for Q1 2021.